NCCN Guidelines: Pretransplant Recipient Evaluation and Management of Graft-Versus-Host Disease

Restricted access

Disclosures: Dr. Cutler is a member of the Board of Directors of the American Society for Transplantation and Cellular Therapy. Dr. Pavletic is on the Steering Committee of the NIH Chronic GVHD Consensus Project. All opinions expressed in this article are the authors’ own and do not necessarily reflect positions of their institutions, organizations, or the U.S. government.

Correspondence: Steven Z. Pavletic, MD, MS, Center for Cancer Research, National Cancer Institute, 10 Center Drive, Room 10/CRC 4-3130, Bethesda, MD 20892. Email: pavletis@mail.nih.gov

View associated content

  • 1.

    Zeiser R, Blazar BR. Acute graft-versus-host disease: biologic process, prevention, and therapy. N Engl J Med 2017;377:21672179.

  • 2.

    Lee SJ, Wolff D, Kitko C, Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group Report. Biol Blood Marrow Transplant 2015;21:984999.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3.

    Cutler CS, Koreth J, Ritz J. Mechanistic approaches for the prevention and treatment of chronic GVHD. Blood 2017;129:2229.

  • 4.

    Majhail NS, Rizzo JD, Lee SJ, Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2012;18:348371.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Martin PJ, Rizzo JD, Wingard JR, First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2012;18:11501163.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Harris AC, Young R, Devine S, International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium. Biol Blood Marrow Transplant 2016;22:410.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Schoemans HM, Lee SJ, Ferrara JL, EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment. Bone Marrow Transplant 2018;53:14011415.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Przepiorka D, Weisdorf D, Martin P, 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995;15:825828.

  • 9.

    Levine JE, Braun TM, Harris AC, A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study. Lancet Haematol 2015;2:e2129.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    Carpenter PA, Kitko CL, Elad S, National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant 2015;21:11671187.

    • Crossref
    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 416 416 283
PDF Downloads 132 132 100
EPUB Downloads 0 0 0